Case for a role of the microbiome in gynecologic cancers

Clinician's perspective

Ismail Mert, Marina Walther-Antonio, Andrea Mariani

Research output: Contribution to journalReview article

2 Citations (Scopus)

Abstract

In this review, we aimed to provide insight into the microbiome and its association with endometrial and ovarian cancer and their risk factors. We reviewed the literature focusing on the relationship between the microbiome and cancer, as well as the relationship between gynecologic diseases and cancers. The human body contains different kinds of microorganisms in various body parts, which is termed the microbiome. The number of microorganisms that live in and on the human body is greater than that of the human germ and somatic cells by 10-fold. The relationship between a human and their microbiome is complex; it is also one of the most important components of homeostasis. Impairment of microbiome–host homeostasis has been associated with obesity, several cancers, preterm labor, inflammatory and allergic conditions and neurodevelopmental disorders. Direct and strong causal relationships have been established for several cancers and microorganisms, such as gastric lymphoma and Helicobacter pylori infection. Interestingly, eradication of the infectious agents has also been shown to be therapeutic. The association between cancer and the microbiome, however, is more complicated than a 1 bacteria–1 cancer model, and a shift in a healthy microbiome can result in various cancers via inflammation, change in microenvironment or DNA-damaging toxins. The human microbiome is an integral part of homeostasis. Understanding the mechanisms that cause dysbiosis will enable us to elucidate the pathways that result in malignancy and investigate new treatment modalities.

Original languageEnglish (US)
Pages (from-to)1693-1704
Number of pages12
JournalJournal of Obstetrics and Gynaecology Research
Volume44
Issue number9
DOIs
StatePublished - Sep 1 2018

Fingerprint

Microbiota
Neoplasms
Human Body
Homeostasis
Female Genital Diseases
Dysbiosis
Premature Obstetric Labor
Helicobacter Infections
Endometrial Neoplasms
Germ Cells
Helicobacter pylori
Ovarian Neoplasms
Obesity
Inflammation
DNA

Keywords

  • endometrial cancer
  • microbiome
  • ovarian cancer

ASJC Scopus subject areas

  • Obstetrics and Gynecology

Cite this

Case for a role of the microbiome in gynecologic cancers : Clinician's perspective. / Mert, Ismail; Walther-Antonio, Marina; Mariani, Andrea.

In: Journal of Obstetrics and Gynaecology Research, Vol. 44, No. 9, 01.09.2018, p. 1693-1704.

Research output: Contribution to journalReview article

@article{f23b60a66db34e4998d1c43a0ccea55d,
title = "Case for a role of the microbiome in gynecologic cancers: Clinician's perspective",
abstract = "In this review, we aimed to provide insight into the microbiome and its association with endometrial and ovarian cancer and their risk factors. We reviewed the literature focusing on the relationship between the microbiome and cancer, as well as the relationship between gynecologic diseases and cancers. The human body contains different kinds of microorganisms in various body parts, which is termed the microbiome. The number of microorganisms that live in and on the human body is greater than that of the human germ and somatic cells by 10-fold. The relationship between a human and their microbiome is complex; it is also one of the most important components of homeostasis. Impairment of microbiome–host homeostasis has been associated with obesity, several cancers, preterm labor, inflammatory and allergic conditions and neurodevelopmental disorders. Direct and strong causal relationships have been established for several cancers and microorganisms, such as gastric lymphoma and Helicobacter pylori infection. Interestingly, eradication of the infectious agents has also been shown to be therapeutic. The association between cancer and the microbiome, however, is more complicated than a 1 bacteria–1 cancer model, and a shift in a healthy microbiome can result in various cancers via inflammation, change in microenvironment or DNA-damaging toxins. The human microbiome is an integral part of homeostasis. Understanding the mechanisms that cause dysbiosis will enable us to elucidate the pathways that result in malignancy and investigate new treatment modalities.",
keywords = "endometrial cancer, microbiome, ovarian cancer",
author = "Ismail Mert and Marina Walther-Antonio and Andrea Mariani",
year = "2018",
month = "9",
day = "1",
doi = "10.1111/jog.13701",
language = "English (US)",
volume = "44",
pages = "1693--1704",
journal = "Journal of Obstetrics and Gynaecology Research",
issn = "1341-8076",
publisher = "Blackwell Publishing Asia",
number = "9",

}

TY - JOUR

T1 - Case for a role of the microbiome in gynecologic cancers

T2 - Clinician's perspective

AU - Mert, Ismail

AU - Walther-Antonio, Marina

AU - Mariani, Andrea

PY - 2018/9/1

Y1 - 2018/9/1

N2 - In this review, we aimed to provide insight into the microbiome and its association with endometrial and ovarian cancer and their risk factors. We reviewed the literature focusing on the relationship between the microbiome and cancer, as well as the relationship between gynecologic diseases and cancers. The human body contains different kinds of microorganisms in various body parts, which is termed the microbiome. The number of microorganisms that live in and on the human body is greater than that of the human germ and somatic cells by 10-fold. The relationship between a human and their microbiome is complex; it is also one of the most important components of homeostasis. Impairment of microbiome–host homeostasis has been associated with obesity, several cancers, preterm labor, inflammatory and allergic conditions and neurodevelopmental disorders. Direct and strong causal relationships have been established for several cancers and microorganisms, such as gastric lymphoma and Helicobacter pylori infection. Interestingly, eradication of the infectious agents has also been shown to be therapeutic. The association between cancer and the microbiome, however, is more complicated than a 1 bacteria–1 cancer model, and a shift in a healthy microbiome can result in various cancers via inflammation, change in microenvironment or DNA-damaging toxins. The human microbiome is an integral part of homeostasis. Understanding the mechanisms that cause dysbiosis will enable us to elucidate the pathways that result in malignancy and investigate new treatment modalities.

AB - In this review, we aimed to provide insight into the microbiome and its association with endometrial and ovarian cancer and their risk factors. We reviewed the literature focusing on the relationship between the microbiome and cancer, as well as the relationship between gynecologic diseases and cancers. The human body contains different kinds of microorganisms in various body parts, which is termed the microbiome. The number of microorganisms that live in and on the human body is greater than that of the human germ and somatic cells by 10-fold. The relationship between a human and their microbiome is complex; it is also one of the most important components of homeostasis. Impairment of microbiome–host homeostasis has been associated with obesity, several cancers, preterm labor, inflammatory and allergic conditions and neurodevelopmental disorders. Direct and strong causal relationships have been established for several cancers and microorganisms, such as gastric lymphoma and Helicobacter pylori infection. Interestingly, eradication of the infectious agents has also been shown to be therapeutic. The association between cancer and the microbiome, however, is more complicated than a 1 bacteria–1 cancer model, and a shift in a healthy microbiome can result in various cancers via inflammation, change in microenvironment or DNA-damaging toxins. The human microbiome is an integral part of homeostasis. Understanding the mechanisms that cause dysbiosis will enable us to elucidate the pathways that result in malignancy and investigate new treatment modalities.

KW - endometrial cancer

KW - microbiome

KW - ovarian cancer

UR - http://www.scopus.com/inward/record.url?scp=85053055344&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85053055344&partnerID=8YFLogxK

U2 - 10.1111/jog.13701

DO - 10.1111/jog.13701

M3 - Review article

VL - 44

SP - 1693

EP - 1704

JO - Journal of Obstetrics and Gynaecology Research

JF - Journal of Obstetrics and Gynaecology Research

SN - 1341-8076

IS - 9

ER -